Background
==========

Spinocerebellar ataxias (SCAs) are autosomal-dominant neurodegenerative diseases that are clinically and genetically heterogeneous. SCAs are characterized by a range of neurological symptoms, including loss of balance and motor coordination, which are caused by progressive dysfunction of the cerebellum and its afferent and efferent connections. Clinical diagnosis of specific subtypes is difficult because of the overlap of phenotypes among genetic subtypes and the variability in clinical features found within distinct genetic subtypes. SCA12 is an autosomal-dominant (AD) ataxia caused by a CAG repeat expansion mutation in a presumed promoter region of the gene PPP2R2B in a non-coding region on chromosome 5q32. Srivastava et al. \[[@b1-medscimonit-20-1783]\] determined that SCA12 is very rare, accounting for only 6.5% of all AD cases. Pathogenesis is likely caused by repetition, amplification, and mutation of CAG, which can affect the transcription of the promoter. The structure of 1 shear transcription of PPP2R2B or other types of genetic expression can change the conformation and functions of the adjusting subunit of protein phosphatase 2A to strengthen chondriokinesis, thereby resulting in neuronic pathology. An action tremor is a prominent feature in SCA12, and is often the presenting neurologic sign. Action tremors then gradually develop into ataxia gait, head tremor, hypokinesia, abnormal eye movements, and tendon hyperreflexia; in patients with dementia, mood disorders may occur \[[@b2-medscimonit-20-1783]--[@b6-medscimonit-20-1783]\].

Atrophy of both the cerebral cortex and cerebellum has been reported on either computed tomography (CT) or brain magnetic resonance imaging (MRI) images from SCA12 patients in a North American kindred and Indian SCA12 patients. Generalized cerebral cortical atrophy is accompanied by moderate ventriculomegaly. Basal ganglia and brainstem structures are relatively preserved. The vermis of the cerebellum appears more atrophic than the cerebellar hemispheres. No focal signal abnormalities in grey or white matter have been reported in SCA12 brain images \[[@b6-medscimonit-20-1783]\].

Neuropathology of the SCA12 proband revealed atrophy of the cerebral cortex and cerebellum plus mild pontine atrophy. Microscopic examination of this SCA12 brain demonstrated moderate-to-marked Purkinje cell loss and atrophy of the cerebellar granule cell layer. Neuronal intranuclear inclusions were found in dopamine neurons of the substantia nigra, Purkinje cells, and rare motor cortical neurons.

Diffusion tensor imaging (DTI) refers to the use of water molecule diffusion anisotropy of nerve fibers in multiple directions on a diffusion-sensitive gradient. DTI detects each individual element of water molecular diffusion anisotropy, and reflects the fine structure of cerebral white matter fiber tracts of damage through the obtained fractional anisotropy (FA) and apparent diffusion coefficient (ADC) values. DTI provides a non-invasive method of showing living brain white matter nerve fiber access, reflects the diffusion of water molecules, and provides a quantitative description of organization by diffuse anisotropy. DTI has potential for broad clinical application. ADC mainly reflects the diffusion speed of water molecules without indicating the direction of movement. When nerve degeneration occurs, nerve cell loss and myelin depigmentation increase the movement of water molecules. Therefore, the rate of diffusion of water molecules increases, and anisotropy decreases. The FA value can reflect the consistency of nerve fibers, structural tightness, and integrity of microstructure. ADC and FA values obtained from DTI have gained widespread acceptance as sensitive indicators to quantify microstructural damage of gray and white matter in neurodegenerative diseases. ADC and FA values have recently been used in the study of SCAs. The evaluation of deep cerebellar nuclei (DCN) using DTI can serve as a simple imaging biomarker of cerebellar disease.

As of this writing, reports on SCA12 using DTI analysis are rare. In this study, changes in ADC and FA in SCA12 were investigated to determine whether they cause damage to white matter. Significant correlations of ADC and FA with disease course and clinical scores were also determined. By detecting different types of micro-damage in brain white matter structure in the presymptomatic patients and a control group of a large Uighur SCA12 pedigree using DTI, morphological markers were found to have an important function in early judgment of the morbidity situation of presymptomatic patients and the quantitative assessment of the severity of disease in patients.

Material and Methods
====================

Data
----

Participants were Uyghur patients and their family members preliminarily diagnosed with SCA based on the Harding standard. Data from 1 Uyghur pedigree were collected, among which 13 cases were patients and 54 cases are "healthy" individuals from Xinjiang. The study used the tracking investigation method and selected 1 Uyghur pedigree using the following criteria: (1) with pedigree analysis, the genetic mode of the disease in the family are autosomal-dominant inheritance; (2) chronic progressive disorder of cerebellar ataxia was the main clinical manifestation; (3) imaging changes in the cerebellum and brainstem atrophy as the main features.

Exclusion criteria: Other diseases that can cause cerebellar ataxia, like multiple sclerosis, cerebellar tumor, inflammation, and cerebral vascular diseases.

The diagnosis was genetically confirmed by means of polymerase chain reaction (PCR) of the gene expansions, agarose gel electrophoresis, and T carrier molecular cloning technology, to be combined with digestion identification and other techniques as described elsewhere. The genetics-based diagnosis of SCA12 patients, including 7 male patients and 6 female patients, with average disease onset age of 43.00±6.56 years old and the mean course of the disease was (6.92±4.82) years. In 5 presymptomatic patients (2 male, 3 female), average age at disease onset was (31.12±2.56) years old. The control group included 15 healthy Uyghur individuals without blood relationship and with average age of 35.65±3.75 years. Five presymptomatic patients with SCA12 and 13 other patients were scanned as part of a locally approved multicenter study. We obtained written informed consent from all participants, in accordance with institutional guidelines and with the Helsinki declaration.

The clinical characteristics of the patients are given in [Table 1](#t1-medscimonit-20-1783){ref-type="table"} and [2](#t2-medscimonit-20-1783){ref-type="table"}. We also enrolled 3.15 age-matched controls (7 male and 8 female, age 38.36±3.46 years) without a history of neurologic disturbances, with normal results on brain MR imaging, who did not smoke, drink, or take medications that act on the CNS.

The protocol of the study was approved by the medical Ethics Committee of the First Affiliated Hospital of Xinjiang Medical University (Approval No. 20090822007).

MRI
---

On the day of scanning, patients were assessed by a senior neurologist using the Scale for the Assessment and Rating of Ataxia (SARA), which quantifies the degree of neurologic impairment, with scores ranging from 0 (no ataxia) to 40 (most severe ataxia) ([Table 1](#t1-medscimonit-20-1783){ref-type="table"}).

We used an Achieva 1.5T double-gradient magnetic resonance scanner (Philips) and an 8-channel head coil SENSE. The scanning methods employed included conventional scan and DTI scan. The conventional scanning line used the conventional spin-echo sequences for T1WI and T2WI. DTI cross-sectional scan levels were consistent with conventional MRI, and diffusion-weighted single-excitation SE-EPI sequences were used.

DTI
---

DTI was performed with a twice-refocused, single-shot, spin-echo echo-planar sequence, using 15 directions and b=1000 s/mm^2^. The following conditions were used in DTI: TR, 2644 ms; TE, 55.0 ms; NEX, 1; 256×256 matrix; FOV, 230×230 mm; thickness, 6.0 mm; and no intersection gap.

Original data were collected in a post-processing workstation and a post-processing "dispersion" software package was used to establish the ADC and FA values. Transverse bitmap T1WI and T2WI were used as a reference, and placed in regions of interest (ROIs). The approximate ROI was selected in the contralateral corresponding parts. The ROI size was about 7 mm. To increase accuracy, a high-definition positioning FLAIR figure was selected. A FLAIR map matching positioning was then employed to outline the ROI area in the bilaterally symmetric cerebral hemisphere. ADC and FA were measured with planar circular ROIs positioned on the DTI color maps jointly by 2 neuroradiologists blinded to patient identity, clinical data, and structural imaging. The FA and DC values were determined in each ROI, and were subsequently measured 3 times. The data were then averaged. ROI was positioned mainly in the following regions: the corticospinal tract (CST) at the level of the pons (pons), superior peduncle (SCP), middle cerebellar peduncle (MCP), cerebellar cortex (CeC), cerebral cortex (CC), and cerebellar vermis (CV) white matter.

Statistical analysis
--------------------

Six different positions of the ADC and FA values were measured in 3 groups (patients, presymptomatic patients, and control group). Data were inputted using SPSS19.0 software. A normal distribution of the obtained data was shown using the normality test and distribution curve. Differences among the 3 groups in 6 different positions of the 2 indicators (ADC and FA values) were examined and the Kruskal-Wallis H test was used for the 3 groups and the Wilcoxon test was used for multiple-comparison. For SCA12 patients, multiple linear correlation analysis was used to determine any correlations in the CAG repeat frequency, duration, SARA score, and different position between the ADC and FA values. Data are expressed as mean ± standard deviation. The significance level was set at P\<0.05.

Results
=======

MRI
---

The standard for the evaluation of encephalatrophy degrees is: 0 stands for normal brain structure, 1 is for mild encephalatrophy (deepening anfractuosity and thinning gyrus), 2 is for moderate encephalatrophy (more obvious deepening of anfractuosity, thinning gyrus with obvious shrinking, and mild expansion to the ventricle), and 3 is for serious encephalatrophy (anfractuosity deepening to alba, thinning gyrus with obvious shrinkage, and obvious expansion in the ventricle and cistern) ([Table 2](#t2-medscimonit-20-1783){ref-type="table"}).

To summarize the MRI manifestations of patients with SCA12: 9 cases had cerebral cortex shrinkage in the frontal lobe, parietal lobe, and other parts; 12 cases exhibited shrinkage in the CV, overall shrinkage in the cerebellar hemispheres characterized by deepening and widening of anfractuosity in the epencephalon cortex and thinning of gyrus; and 7 cases had brainstem atrophy, including volume shrinkage in pons and medulla, expansion of the pons forebay, and other characteristics ([Figure 1](#f1-medscimonit-20-1783){ref-type="fig"}).

DTI
---

The Kruskal-Wallis H test was used in the 3 groups. Based on the different positions of ADC values, no statistically significant difference was found in the positions of the MCP and CST pons among the 3 groups (P\>0.05). By contrast, the positions in the SCP, CeC, CC, and CV white matter were found to be significantly different among the 3 groups (P\<0.05). The Wilcoxon test was used for multiple-comparison. The results showed a statistically significant difference in the positions of the SCP, CeC, CC, and CV white matter between the patients and normal group (P\<0.05). ADC values in the patients were higher than those in the normal group, and the position of CV white matter was significantly different between the patients and presymptomatic patients (P\<0.05).

The Kruskal-Wallis H test was used in the 3 groups. Based on the different positions of FA values, significant differences in the positions of the SCP, CC, and CV were observed among the 3 groups (P\<0.05). The Wilcoxon test was used for multiple-comparison. The results show that the position of the CC was significantly different between the patients and normal group (P\<0.05). FA values in the patients were lower than those in the normal group. Significant differences in the positions of the CV and CC were observed between the presymptomatic patients and normal group (P\<0.05). FA values in the presymptomatic patients were lower than those in the normal group in the CV.

Randomized differential analysis was employed in the 3 groups. The results show that the positions of the CST (pons), SCP, MCP, CeC, CC, and CV white matter were significantly different based on the 2 indicators (ADC and FA values) among the 3 groups (P\<0.05).

Correlation analysis showed that the SARA score was correlated with ADC in the CV white matter (r=0.72, P\<0.05). Disease duration was correlated with ADC in the CV white matter (r=0.71, P\<0.05) ([Table 3](#t3-medscimonit-20-1783){ref-type="table"}, [Figures 2](#f2-medscimonit-20-1783){ref-type="fig"}, [3](#f3-medscimonit-20-1783){ref-type="fig"}).

Discussion
==========

DTI revealed disease-specific DCN changes in cerebellar degeneration. These changes mediate virtually all cerebellar outflows along with the vestibular nuclei. Quantitative assessment of the DCN may be invaluable to diagnosis, staging, and prognosis in neurodegenerative diseases with cerebellar involvement. DTI evaluation of the DCN can serve as a simple imaging biomarker of cerebellar disease \[[@b7-medscimonit-20-1783]--[@b10-medscimonit-20-1783]\]. Sajjadi et al. showed that neurodegenerative disease is identifiable in a single subject with DTI \[[@b11-medscimonit-20-1783]\]. Neuroimaging evidence of microstructural changes consistent with neurodegeneration has been found in patients with familial essential tremor \[[@b12-medscimonit-20-1783]\].

DTI reveals disease-specific DCN changes in cerebellar degeneration. The method used in this study should be applied to SCA3 and Friedreich's ataxia, which may show significant dentate involvement. Based on the aforementioned studies, it is important to use DTI for quantifying the microstructural damage to white matter in neurodegenerative diseases caused by SCA12 \[[@b13-medscimonit-20-1783]--[@b16-medscimonit-20-1783]\].

The detection of SCA12 subtypes of microstructural damage in cerebral white matter using DTI has not been reported in detail. O'Hearn et al. reported that no focal signal abnormalities in grey or white matter have been reported in SCA12 brain images. In the present study, some differences in ADC values in the CV of the patients and presymptomatic patients \[[@b6-medscimonit-20-1783],[@b17-medscimonit-20-1783]\] were found. Moreover, the presymptomatic patients and control group exhibited differences in the positions of the CeC and CC. FA values of the presymptomatic patients and control group decreased in the CV region, which may indicate the onset of symptoms in patients with pre-existing microstructural damage in cerebral white matter of the CV \[[@b17-medscimonit-20-1783]--[@b19-medscimonit-20-1783]\]. Thus, the detection of DTI changes in the assessment of the structural damage in white matter of the CV may be used as relatively objective morphological markers to assess the outcome in presymptomatic patients.

Mandelli et al. \[[@b19-medscimonit-20-1783]\] reported that DTI does not differ between SCA1 and SCA2. However, strongly significant differences were found between the 2 subtypes compared with the controls, and correlations with clinical scores were detected. Compared with the controls, ADC significantly increased in the MCP and hemispheric white matter in SCA1, and in all regions under consideration in SCA2. Reports on other subtypes of white matter damage using DTI detection are rare \[[@b20-medscimonit-20-1783]--[@b23-medscimonit-20-1783]\].

The results in our study show that the course of the disease and ADC values of CV were highly positively correlated (r=0.71). SARA score and ADC values of CV also showed a highly positive correlation (r=0.72). Damage in the brain white matter fiber structure of the CV could reflect the severity of damage of SCA12 nerve pathology. This finding was consistent with the report of O'Hearn et al., who found that the CV appears more atrophic than the cerebellar hemispheres. Thus, our results suggest that neurodegenerative pathology of CeC and CV white matter structures may have a key function in disease onset.

Further studies are necessary to assess the function of FA and mean diffusivity changes in the differential diagnosis of SCA12, which may present similar clinical signs at disease onset. Although the degree of atrophy was not measured quantitatively, visual assessment performed in clinical practice was determined to be adequate for the purpose of the present study. Although a certain margin for rating subjectivity remained, blinding prevented bias \[[@b24-medscimonit-20-1783]--[@b26-medscimonit-20-1783]\].

Diffusion tensor tractography is an excellent tool for imaging individual white matter tracts. However, the technical limitations of this method should be considered, particularly problems concerning fiber crossing, delineation of tracts using manually drawn ROIs, and distortion of axonal and neuronal architecture in neurodegenerative diseases; these limitations make it difficult for the tracking algorithm to follow the fibers over longer distances or changes in direction \[[@b19-medscimonit-20-1783],[@b27-medscimonit-20-1783],[@b28-medscimonit-20-1783]\].

Conclusions
===========

DTI is useful in differentiating patients with SCA12, but has limitations when used in the presymptomatic patients and controls because of the substantial overlap among the 3 groups. The strongly significant differences and correlations with clinical scores suggest an important function in combination with structural imaging characterizing the phenotypes, and provide a quantitative measure of disease severity.

Data
----

Data from a single Uyghur pedigree were collected, among which 13 cases were patients and 54 cases were "healthy" individuals from Xinjiang.
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###### 

The clinical characteristics and SARA rating for 13 cases with SCA12.

  Patient No.                       IV-1       III-5      IV-7       III-8      III-10     III-18     IV-2       IV-4       IV-9       IV-21      IV-11      IV-14      IV-16
  --------------------------------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ----------
  Gender                            Female     Male       Female     Male       Female     Male       Male       Male       Male       Male       Female     Female     Female
  Age at present                    48         61         47         54         59         55         42         41         41         44         38         48         43
  Onset age                         44         53         42         53         48         40         40         39         33         42         36         41         40
  Course of disease                 4          8          5          1          11         15         7          2          8          2          2          7          3
  CAG Repetition times              48         50         52         51         50         54         49         49         48         50         52         50         50
  Unstable walking                  −          Serious    \+         \+         \+         Serious    −          \+         \+         \+         \+         Serious    −
  Alalia                            −          Obvious    \+         \+         \+         Obvious    −          −          \+         \+         \+         \+         −
  Tremble in upper limbs            Mild       Obvious    Moderate   Moderate   Without    Obvious    Mild       Moderate   Moderate   Moderate   −          Obvious    Mild
  Dysphagia                         −          \+         −          −          −          With       −          −          −          −          −          \+         −
  Diminution of vision              −          \+         −          −          −          −          −          −          −          −          −          −          −
  Nystagmus and slow eye movement   −          Obvious    \+         −          −          −          −          −          \+         −          \+         Obvious    −
  Orthostatic dizziness             −          Obvious    \+         \+         \+         Obvious    −          −          \+         \+         \+         Obvious    −
  Amyotrophy                        −          −          −          −          −          −          −          −          −          −          −          −          −
  Muscular tension                  Normal     Enhanced   Normal     Normal     Normal     Active     Normal     Enhanced   Normal     Normal     Normal     Active     Healthy
  Tendon reflex                     Enhanced   Active     Enhanced   Enhanced   Enhanced   Active     Normal     Active     Enhanced   Active     Enhanced   Active     Healthy
  Pathological reflex               Negative   Positive   Positive   Positive   Positive   Positive   Negative   −          Positive   Negative   Positive   Positive   Negative
  Sensory disturbance               −          \+         −          −          −          −          −          \+         −          −          −          −          −
  Intelligence declining            −          \+         −          −          \+         \+         −          \+         −          −          \+         \+         −
  SARA grade (marks)                9          28         25         12         32         35         5          19         15         12         23         28         11

CAG -- indicates cytosine adenine guanine.

###### 

Encephalatrophy grading in different position.

  Patient No.   Duration of disease   Encephalatrophy grading                           
  ------------- --------------------- ------------------------- --- --- --- --- --- --- ---
  SCA12-1       15                    2                         2   0   0   1   3   1   3
  SCA12-2       11                    1                         1   0   1   1   2   3   3
  SCA12-3       8                     1                         1   0   0   0   1   0   2
  SCA12-4       8                     1                         0   0   0   0   1   0   1
  SCA12-5       7                     1                         1   0   0   0   0   0   1
  SCA12-6       7                     1                         0   0   0   0   0   0   1
  SCA12-7       5                     1                         0   0   0   0   0   0   0
  SCA12-8       4                     1                         0   0   0   0   0   0   1
  SCA12-9       3                     0                         0   0   0   0   0   0   0
  SCA12-10      2                     0                         0   0   0   0   0   0   0
  SCA12-11      2                     0                         0   0   0   0   0   0   0
  SCA12-12      2                     0                         0   0   0   0   0   0   0
  SCA12-13      1                     0                         0   0   0   0   0   0   0

###### 

Results from post hoc comparisons for ADC, FA between patients, presymptomatic patients and controls with SCA12, the comparison results between three groups.

               Patients      Pre-          Control       χ^2^    P                                                          Patients-control                                           Pre-control                                                Patients-pre
  ------------ ------------- ------------- ------------- ------- ---------------------------------------------------------- ---------------------------------------------------------- ---------------------------------------------------------- ----------------------------------------------------------
  ADS                                                                                                                                                                                                                                             
  CeC          0.776±0.075   0.739±0.013   0.740±0.015   13.58   [\*](#tfn3-medscimonit-20-1783){ref-type="table-fn"}       [\*](#tfn3-medscimonit-20-1783){ref-type="table-fn"}       ns                                                         ns
  CV           0.869±0.078   0.800±0.045   0.784±0.040   10.25   [\*\*](#tfn4-medscimonit-20-1783){ref-type="table-fn"}     [\*\*\*](#tfn5-medscimonit-20-1783){ref-type="table-fn"}   ns                                                         [\*](#tfn3-medscimonit-20-1783){ref-type="table-fn"}
  CC           0.793±0.048   0.772±0.034   0.753±0.012   18.34   [\*](#tfn3-medscimonit-20-1783){ref-type="table-fn"}       [\*\*](#tfn4-medscimonit-20-1783){ref-type="table-fn"}     ns                                                         ns
  MCP          0.735±0.042   0.747±0.039   0.741±0.011   6.38    ns                                                         ns                                                         ns                                                         ns
  SCP          0.780±0.036   0.774±0.023   0.746±0.020   19.58   [\*\*](#tfn4-medscimonit-20-1783){ref-type="table-fn"}     [\*\*](#tfn4-medscimonit-20-1783){ref-type="table-fn"}     ns                                                         ns
  CST (pone)   0.846±0.046   0.890±0.079   0.877±0.022   2.27    ns                                                         ns                                                         ns                                                         ns
  PA                                                                                                                                                                                                                                              
  CeC          0.365±0.032   0.370±0.034   0.373±0.007   1.24    ns                                                         ns                                                         ns                                                         ns
  CV           0.364±0.036   0.428±0.039   0.357±0.019   27.22   [\*\*\*](#tfn5-medscimonit-20-1783){ref-type="table-fn"}   ns                                                         [\*\*\*](#tfn5-medscimonit-20-1783){ref-type="table-fn"}   [\*\*\*](#tfn5-medscimonit-20-1783){ref-type="table-fn"}
  CC           0.333±0.037   0.346±0.010   0.313±0.007   11.68   [\*](#tfn3-medscimonit-20-1783){ref-type="table-fn"}       [\*](#tfn3-medscimonit-20-1783){ref-type="table-fn"}       [\*](#tfn3-medscimonit-20-1783){ref-type="table-fn"}       ns
  MCP          0.443±0.037   0.450±0.089   0.435±0.023   1.37    ns                                                         ns                                                         ns                                                         ns
  SCP          0.463±0.038   0.412±0.066   0.445±0.026   4.78    ns                                                         ns                                                         ns                                                         [\*](#tfn3-medscimonit-20-1783){ref-type="table-fn"}
  CST (pone)   0.465±0.027   0.420±0.081   0.452±0.021   6.25    ns                                                         ns                                                         ns                                                         [\*](#tfn3-medscimonit-20-1783){ref-type="table-fn"}

CST(pons) -- indicates corticospinal tract at the level of the pons; SCP -- in the superior peduncle; MCP -- middle cerebellar peduncle; CeC -- in the Cerebellar Cortex; CC -- in the Cerebral Cortex; CV -- in the Cerebellar vermis white matter. Pre -- indicates Presymptomatic patients. n.s. -- not significant. Values are expressed as mean ±SD.

P=.05;

P=.01;

P=.001.
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